Healthcare Market Research Reports

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 19 Jun 2024  |  Global  |  Technology Research

    Molecular Diagnostics for Neurodegenerative Diseases: Technology Growth Opportunities, 2024 2028

    Leveraging integrated and point-of-care diagnostics with multiomics represents the most promising growth opportunity to advance molecular diagnostics for neurodegenerative diseases

    Neurodegenerative diseases (NDD) pose significant challenges to healthcare systems and affect millions of people worldwide, making early detection crucial. While the current diagnostic strategy is predominantly brain imaging techniques, it is not performed until symptoms are more pronounced. Subtle changes occurring in neural cells during early pro...

    $4,950.00
  2. 12 Jun 2024  |  Global  |  Technology Research

    Smartphone-based Point-of-care Testing Innovations and Growth Opportunities

    Growth Potential Enhanced by Advanced AI/ML Algorithms and Miniaturized Molecular Diagnostics

    Smartphone-based point-of-care (POC) diagnostics are rapidly emerging as medical diagnostics, enabling remote or self-monitoring tools for general wellness and a range of health conditions. Smartphones enable low-cost, rapid, and handy POC diagnostics. Intrinsic sensors of smartphones or extrinsic sensing devices working with intelligent data analy...

    $4,950.00
  3. 29 May 2024  |  Global  |  Technology Research

    Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics)

    Rising Popularity Among Tier 1 Pharma Companies and Technological Advances in Drug Delivery Push Biologics Development

    There have been increasing incidences of rare ophthalmic diseases (e.g., retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis) and prevalent diseases (e.g., age-related macular degeneration [AMD], geographic atrophy). While clinicians have used small molecules as the conventional therapeutic modality to manage these diseases, the urg...

    $4,950.00
  4. 14 May 2024  |  Global  |  Frost Radar

    Frost Radar : Multichannel Marketing Hubs, 2024

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    The Frost Radar for the multichannel marketing hub (MMH) industry analyzes providers offering software solutions that help companies streamline and enhance marketing efforts across multiple channels. It plots 12 selected providers based on 10 growth and innovation criteria, comprising quantitative and qualitative factors. The vertical Growth I...

    $4,950.00
  5. 06 May 2024  |  Global  |  Technology Research

    Digital Pathology Technology Innovations and Growth Opportunities

    Disruptive technologies like AI-based image analysis algorithms are boosting diagnostics and drug development research

    The digital pathology industry is witnessing steadily increasing competitive intensity, with the entry of several start-ups putting market players under pressure to create unique, disruptive products. While digital pathology includes slide digitalization, image analysis algorithms, and image storage and management solutions, this report focuses on ...

    $4,950.00
  6. 25 Apr 2024  |  Global  |  Frost Radar

    Frost Radar : Healthcare Enterprise Managed Cloud Services, 2024

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    In the cloud industry and most other technology-related industries, 2024 will be all about artificial intelligence (AI). Businesses are grappling with how they can leverage AI (particularly generative AI) to meet their goals. Public cloud providers are at the forefront of efforts to accelerate customers AI adoption by developing foundational model...

    $4,950.00
  7. 21 Dec 2022  |  Global  |  Technology Research

    Antibody-drug Conjugates: Technology Growth Opportunities

    Disruptive Technologies and a Conducive Funding Environment are Fostering Growth

    Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...

    $4,950.00

    Special Price $4,207.50 save 15 %

  8. 20 Dec 2022  |  Global  |  Technology Research

    Advances and Growth Opportunities in RNA Vaccines

    Technology Innovations and Investments Bolster Next-generation Prophylactic and Therapeutic RNA Vaccines

    RNA therapeutics and vaccines have been around for a long time, but the COVID-19 pandemic enabled their mass-market commercialization. Industry players saw mRNA vaccines developed for COVID-19 as effective for reducing the impact of the SARS-CoV-2 virus in populations. Moderna emerged as the first player to develop and commercialize an mRNA vaccine...

    $4,950.00

    Special Price $4,207.50 save 15 %

  9. 19 Dec 2022  |  Global  |  Technology Research

    Assistive Reproductive Technologies: Innovations and Growth Opportunities

    Non-invasive PGT and AI-based Decision Support Creating Transformational Growth in IVF Procedures

    Assisted reproductive technology (ART) includes advanced fertility treatments and procedures, such as the manipulation of eggs, sperm, or embryos to increase the chances of a successful pregnancy. This study primarily examines the market for in vitro fertilization (IVF), a common ART procedure. It highlights innovations around the pre-implantation ...

    $4,950.00

    Special Price $4,207.50 save 15 %

  10. 19 Dec 2022  |  Global  |  Technology Research

    Technology Innovations and Growth Opportunities in Structural Heart Implants

    Biomaterials and Design Advances Improve the Efficacy and Safety of Heart Valves and Occluders

    Structural heart diseases (SHD) encompass cardiac conditions that cause abnormal blood flow inside the heart's chambers, which can be wrong blood flow direction or blood stagnation. Structural abnormalities in the heart lead to impaired functioning rather than the heart's blood vessels. The cardiovascular implants industry has developed prosthetic ...

    $4,950.00

    Special Price $4,207.50 save 15 %